Pharmaceutical

Sanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine

Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.

May 11, 2024 - 04:00
Sanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine
Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.
Read the original article

Tags:

Previous Article

“What was that?” — How brains convert sounds to actions

Next Article

RAPT terminates Phase II trials for lead candidate following clinical hold

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14

HPV vaccine study finds zero cases of cervical cancer a...

Jan 26, 2024

Health data breaches hit an all-time high in 2023

Health data breaches hit an all-time high in 2023

Dec 21, 2023

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s...

Jul 4, 2024